ARKG
$47.17ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense ratio
0.75%
Dividend yield
0.00%
AUM
$2.21B
Issuer
ARK
YTD return
66.55%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
Sector exposure
Sector breakdown · ARKG
Healthcare100.0%